Skip to main content
TipRanks
Go Ultimate75% OFF

VentriPoint Diagnostics (5V7) AI Stock Analysis

0 Followers
DE:5V7

VentriPoint Diagnostics

(Frankfurt:5V7)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue GrowthStrong TTM revenue growth indicates continued customer adoption and expanding commercial activity. If maintained, this larger revenue base can improve operating leverage, support broader market penetration, and provide a foundation for the company to scale its cardiac imaging software business.
Negative Factors
Negative EquityNegative equity indicates accumulated losses have more than offset invested capital, materially weakening the company’s financial position. Debt relative to the small asset base limits flexibility and increases reliance on external financing, making sustained execution and balance-sheet repair important over the next several quarters.

VentriPoint Diagnostics (5V7) vs. iShares MSCI Germany ETF (EWG)

-50%-25%0%25%50%75%100%DE:5V7-36.73%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 12.54M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-5.0
Beta (1Y)
-0.52
Revenue Growth
79.57%
EPS Growth
40.95%
Country
Germany
Employees
10
Sector
General
Sector Strength
55
Industry
Medical - Devices

VentriPoint Diagnostics Business Overview & Revenue Model

Company Description

VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of th...

VentriPoint Diagnostics Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

DE:5V7 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TSE:PRNTSE:PRN53NeutralCAD 388.24M-8.06-59.18%―64.70%30.61%
TSE:PINKTSE:PINK44NeutralCAD 23.02M-1.15-303.05%―35.27%58.34%
TSE:TLTTSE:TLT41NeutralCAD 57.44M-13.03-130.04%―-24.86%18.29%

* General Sector Average

Performance Comparison

0%100%200%DE:5V7TSE:PINKTSE:PRNTSE:TLTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:5V7 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:5V7VentriPoint Diagnostics0.03-0.02-40.38%
TSE:PINKPerimeter Medical Imaging Ai Inc0.15-0.03-16.67%
TSE:PRNProfound Medical10.601.5417.00%
TSE:TLTTheralase Technologies0.18-0.01-5.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.